A share price of Sunshine Biopharma Inc [SBFM] is currently trading at $3.24, up 8.00%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SBFM shares have gain 13.87% over the last week, with a monthly amount glided 32.20%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sunshine Biopharma Inc experienced fluctuations in its stock price throughout the past year between $2.11 and $608.00. Sunshine Biopharma Inc [NASDAQ: SBFM] shares were valued at $3.24 at the most recent close of the market.
Analyzing the SBFM fundamentals
Trailing Twelve Months sales for Sunshine Biopharma Inc [NASDAQ:SBFM] were 32.96M which represents 41.59% growth. Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.13%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.18 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.03 points at the first support level, and at 2.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.36, and for the 2nd resistance point, it is at 3.47.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sunshine Biopharma Inc [NASDAQ:SBFM] is 5.74. Further, the Quick Ratio stands at 3.57, while the Cash Ratio is 2.7. Considering the valuation of this stock, the price to sales ratio is 0.19, the price to book ratio is 0.25.
Transactions by insiders
Recent insider trading involved Slilaty Steve N., Chief Executive Officer, that happened on Mar 04 ’24 when 100000.0 shares were purchased. Chief Executive Officer, Slilaty Steve N. completed a deal on Feb 08 ’24 to buy 20000.0 shares.
